Isofra (Isofra)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceFramicetinFramicetin
Similar drugsTo uncover
  • Isofra
    spray nazal. 
    Bouchard-Recordati Laboratories     France
    • Dosage form: & nbspnasal spray
    Composition:

    Per 100 ml:

    Active substance:

    Framicetin sulfate 1.25 g, which corresponds to 800,000 YE

    Excipients:

    Methylparahydroxybenzoate 0.100 g

    Sodium chloride 0.756 g

    Sodium citrate 0.106 g

    Citric acid monohydrate 0.040 g

    Water purified to 100 ml

    Description:Transparent colorless liquid.
    Pharmacotherapeutic group:Antibiotic from the group of aminoglycosides
    ATX: & nbsp

    R.01.A.X   Other drugs for topical use in diseases of the nose

    R.01.A.X.08   Framicetin

    Pharmacodynamics:

    Antibiotic from the aminoglycoside group for topical application in otolaryngology. It is bactericidal. Active for most Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae), causing the development of infectious processes in the upper respiratory tract.

    Indications:

    As part of combination therapy for infectious and inflammatory diseases of the upper respiratory tract, including:

    • rhinitis;
    • rhinopharyngitis;
    • sinusitis (in the absence of damage to partitions).

    Preventive maintenance and treatment of inflammatory processes after surgical interventions.

    Contraindications:

    Hypersensitivity to framicetin and other antibiotics from the aminoglycoside group. The drug should not be used to flush the paranasal sinuses.Pregnancy and the period of breastfeeding.

    Pregnancy and lactation:

    Contraindicated in pregnancy and during breastfeeding.

    Dosing and Administration:

    Adults: one injection in each nostril 4-6 times a day.

    For children: one injection every nostril 3 times a day.

    Duration of treatment - no more than 7 days.

    When using the bottle should be kept in a vertical position.

    Side effects:

    Allergic reactions are possible.

    Overdose:

    Due to the low degree of absorption in the systemic blood flow, an overdose is unlikely.

    Interaction:

    Clinically significant drug interactions with other drugs have not been identified.

    Special instructions:FROMIt is worth remembering that the emergence of resistant strains of microorganisms is possible during treatment.
    Form release / dosage:

    The nasal spray is 1.25%.

    Packaging:

    15 ml per polyethylene opaque bottles with a spray tip with polyethylene screw cap.

    One bottle together with the instruction for use is placed in a cardboard box.

    Storage conditions:Store at a temperature not exceeding 25 ° C. Keep out of the reach of children.
    Shelf life:

    3 years.

    Do not use after the expiration date stated on the package

    Terms of leave from pharmacies:On prescription
    Registration number:П N015454 / 01
    Date of registration:15.12.2008 / 09.02.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:Bouchard-Recordati LaboratoriesBouchard-Recordati Laboratories France
    Manufacturer: & nbsp
    Representation: & nbspRUSFIK LLC RUSFIK LLC Russia
    Information update date: & nbsp09.11.2017
    Illustrated instructions
      Instructions
      Up